Health and Fitness Health and Fitness
Wed, January 5, 2011
[ Wed, Jan 05th 2011 ] - Market Wire
Thermo Fisher Scientific to Present at the 29th A .. PMorgan Healthcare Conference on January 11, 2011
[ Wed, Jan 05th 2011 ] - Market Wire
InSite Vision Completes Patient Enrollment in ISV .. Study for Post-Surgical Ocular Pain and Swelling
[ Wed, Jan 05th 2011 ] - Market Wire
MannKind to Present at the JP Morgan 29th Annual HealthcareConference
[ Wed, Jan 05th 2011 ] - Market Wire
Kinetic Concepts, Inc. to Present at the 29th Annual J.P. Morgan Healthcare Conference
[ Wed, Jan 05th 2011 ] - Market Wire
Medisafe 1 Technologies Issues Letter to Shareholders
[ Wed, Jan 05th 2011 ] - Market Wire
PerkinElmer to Present at 29th Annual JP Morgan Healthcare Conference
[ Wed, Jan 05th 2011 ] - Market Wire
Teva Completes Acquisition of Th©ramex
Tue, January 4, 2011
[ Tue, Jan 04th 2011 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Investigation of CPEX Pharmaceuticals, Inc.
[ Tue, Jan 04th 2011 ] - Market Wire
Finkelstein Thompson LLP Announces Investigation of CPEX Pharmaceuticals, Inc.
[ Tue, Jan 04th 2011 ] - Market Wire
Merck to Hold Fourth-Quarter 2010 Sales and Earnings Conference Call on Feb. 3
[ Tue, Jan 04th 2011 ] - Market Wire
The Law Office of Robbins Umeda LLP Announces an .. ion of CPEX Pharmaceuticals, Inc. by FCB I Holdin
[ Tue, Jan 04th 2011 ] - Market Wire
St. Jude Medical to Present at the 29th Annual J.P. Morgan Healthcare Conference
[ Tue, Jan 04th 2011 ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Launches an .. Breaches of Fiduciary Duty by the Board of CPEX P
[ Tue, Jan 04th 2011 ] - Market Wire
Briscoe Law Firm Investigates CPEX Pharmaceutical .. ders Concerning the Acquisition by Footstar, Inc.
[ Tue, Jan 04th 2011 ] - Market Wire
Illumina to Present at J.P. Morgan Healthcare Conference
[ Tue, Jan 04th 2011 ] - Market Wire
BioCryst to Present at J.P. Morgan Healthcare Conference
[ Tue, Jan 04th 2011 ] - Market Wire
Kiadis Pharma Signs License Agreement with Hospira to Commercialize ATIRa" in Europe and Asia
[ Tue, Jan 04th 2011 ] - Market Wire
Bio-Path Holdings to Present at the Biotech Showcasea" 2011 Conference
[ Tue, Jan 04th 2011 ] - Market Wire
ZIOPHARM Oncology Appoints Mark Thornton, M.D., P .. tive Vice President and Chief Development Officer
[ Tue, Jan 04th 2011 ] - Market Wire
AVEO Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
[ Tue, Jan 04th 2011 ] - Market Wire
Pro-Pharmaceuticals to Present Corporate Update at San Francisco Biotech Conference
[ Tue, Jan 04th 2011 ] - Market Wire
Celgene fornisce aggiornamenti su domande sottoposte ad autorit regolamentatrici
[ Tue, Jan 04th 2011 ] - Market Wire
Celgene Provides Update on Regulatory Submissions
[ Tue, Jan 04th 2011 ] - Market Wire
Alnylam Demonstrates RNAi in Man with Systemically Delivered RNAi Therapeutics
[ Tue, Jan 04th 2011 ] - Market Wire
Rigrodsky & Long, P.A. Investigates CPEX Pharmaceuticals, Inc. Buyout
[ Tue, Jan 04th 2011 ] - Market Wire
Kendall Law Group Investigates CPEX Pharmaceuticals, Inc. Acquisition for Shareholders
[ Tue, Jan 04th 2011 ] - Market Wire
Derma Sciences Launches Advanced Wound Care eLearning Portal for Clinicians
Mon, January 3, 2011
[ Mon, Jan 03rd 2011 ] - Market Wire
LecTec Corporation Announces Rescheduled Trial Date
[ Mon, Jan 03rd 2011 ] - Market Wire
Universal American Corp. to Present at the J.P. M .. 29th Annual Healthcare Conference on January 12th
[ Mon, Jan 03rd 2011 ] - Market Wire
Incyte to Present at the 29th Annual J.P. Morgan Healthcare Conference

Incyte to Present at the 29th Annual J.P. Morgan Healthcare Conference


Published on 2011-01-03 13:20:13 - Market Wire
  Print publication without navigation


WILMINGTON, Del.--([ BUSINESS WIRE ])--Incyte Corporation (Nasdaq:INCY) announced today it will present at the 29th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2011 at 7:30 a.m. PT / 10:30 a.m. ET in San Francisco.

The presentation will be webcast live and can be accessed at [ www.incyte.com ] under Investor Relations, Events and Webcasts. A replay of the presentation will be available for 30 days. Investors interested in listening to the live webcast should log on before the start time in order to download any software required.

Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, visit the Company's web site at [ www.incyte.com ].

Contributing Sources